Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 15, 2024

BUY
$25.72 - $29.94 $12.9 Million - $15 Million
501,000 Added 58.14%
1,362,700 $37 Million
Q4 2023

Feb 13, 2024

BUY
$23.42 - $31.74 $20.2 Million - $27.4 Million
861,700 New
861,700 $26.7 Million
Q4 2017

Feb 14, 2018

SELL
$26.43 - $31.78 $7.05 Million - $8.48 Million
-266,800 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$11.61 - $31.21 $3.1 Million - $8.33 Million
266,800
266,800 $8.33 Million

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $8.98B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Sio Capital Management, LLC Portfolio

Follow Sio Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sio Capital Management, LLC with notifications on news.